NEHTA should have nothing to fear from encouraging open communications with the clinical fraternity. Indeed even at this early stage Mr Reinecke should be thinking , and perhaps he is, of how best to engage the clinical fraternity; for not to do so will only serve to undermine NEHTA's credibility with one of its most important stakeholders. This however, does not hold true, if NEHTA sees its role as simply being one of putting in place the 'key pieces' of the puzzle which clinicians may opt to embrace voluntarily, or be driven to embrace through application of some form of 'carrot and stick' incentive. It should not be unreasonable for NEHTA to make known from whom it is receiving its clinical advice. In a project as complex and demanding as NEHTA is undertaking - secrecy reflects adversely on its leadership and serves no-one.

Dr Ian Colclough
Integrated Marketing & e-Health Strategies
0412 059 392
_______________________________________________
Gpcg_talk mailing list
[email protected]
http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk

Reply via email to